IL2 and type 1 diabetes mellitus: A tolerogenic DNA vaccination with autoantigen-encoding plasmids in combination with plasmids for either TGF-β, IL-10, and or IL-2 suppressed disease in EAE (94) and T1D (95) (Table 5).